Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity-Reference-Cited by-同舟云学术

Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity

Published:2013-10 Issue:10 Volume:2 Page:e26527
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Boissel Laurent,Betancur Monica,Lu Weiquan,Krause Daniela,Van Etten Richard,Wels Winfried,Klingemann Hans

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/onci.26527

Reference33 articles.

1. Effective immunochemotherapy for aggressive non-Hodgkin’s lymphoma;Coiffier;Semin Oncol,2004

2. Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma;Micallef;Blood,2011

3. Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?;Bacher;Blood,2012

4. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia;Porter;N Engl J Med,2011

5. Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy;Ramos;Expert Opin Biol Ther,2011

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene delivery;Journal of Nanobiotechnology;2024-09-10

2. The basic biology of NK cells and its application in tumor immunotherapy;Frontiers in Immunology;2024-08-16

3. Enhanced non-viral gene delivery via calcium phosphate/DNA co-precipitates with low-voltage pulse electroporation in NK-92 cells for immunocellular therapy;APL Bioengineering;2024-08-06

4. Cathepsin B causes trogocytosis-mediated CAR T cell dysfunction;2024-06-14

5. Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies;Biological Chemistry;2024-05-21